
Arcorp Pharmaceuticals Private Limited
About Arcorp Pharmaceuticals Private Limited
Data last updated:
Arcorp Pharmaceuticals Private Limited is a private limited company based in Bhopal, Madhya Pradesh, India, recognised as a startup by DPIIT. It operates in the medical equipment retail and distribution segment of the healthcare sector. It was incorporated on 05 December 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Gwalior, under CIN U24239MP2019PTC050263. Its GSTIN is 23AATCA0145L1ZM (Madhya Pradesh).
The company has an authorised share capital of ₹25 Lakh and a paid-up capital of ₹25 Lakh. It is led by directors Anjna Singh and Shiksha Singh.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 91B See Brass Appartment Zone – II M.P Nagar, Bhopal, Madhya Pradesh, India – 462011.
As per the financials filed for FY 2024, the company reported a revenue of ₹1.69 Lakh, a decline of 98% compared to the previous year. For the same year it recorded a net loss of ₹3.2 Lakh (net margin -189.5%) and EBITDA of -₹2.5 Lakh (EBITDA margin -148.2%). Revenue has declined at a compounded annual rate (CAGR) of 68% over three years.
Company details
Recognitions & Rankings of Arcorp Pharmaceuticals
Contact details
Arcorp Pharmaceuticals Private Limited's registered office is in Bhopal, Madhya Pradesh. Its e-mail address is in the company report.
- Email
- Registered Address91B See Brass Appartment Zone – II M.P Nagar, Bhopal, Madhya Pradesh, India – 462011
- IndustryHealthcare, Medical Equipment Retail & Distribution
To see the full contact details of Arcorp Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Arcorp Pharmaceuticals Private Limited
FY 2025 filings availableArcorp Pharmaceuticals Private Limited reported revenue of ₹1.69 Lakh (down 98% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 68% over three years, including a 98% fall in the latest year. EBITDA fell 196% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹2.5 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹3.2 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -148.2% | ||||
| Net Profit Margin | -189.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Arcorp Pharmaceuticals Private Limited, buy the company report.
Board of directors of Arcorp Pharmaceuticals Private Limited
Arcorp Pharmaceuticals has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Anjna Singh | Director | 05 Dec 2019 | 6 Years 11 Months | Current |
| Shiksha Singh | Director | 26 Feb 2024 | 2 Years 8 Months | Current |
Peer comparison
Arcorp Pharmaceuticals Private Limited is compared with the 10 companies closest to it by revenue in the Healthcare industry (Healthcare Equipment Retail and Distribution, Pharmaceuticals), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Ecolab Scientific Private Limited | ₹1.71 Lakh (FY 2024) | Kolkata, West Bengal, India | ||||
| Rivoma Pharmaceuticals Private Limited | ₹1.7 Lakh (FY 2025) | -62.0% | Chandrapur, Maharashtra, India | |||
| Doctor Choice Pharmaceuticals Private Limited | ₹1.69 Lakh (FY 2025) | -58.0% | Faridabad, Haryana, India | |||
| Raquel Pharmaceuticals Private Limited | ₹1.69 Lakh (FY 2020) | -88.0% | Vadodara, Gujarat, India | |||
| Insta Medsystems Private Limited | ₹1.69 Lakh (FY 2017) | Navi Mumbai, Maharashtra, India | ||||
| Arcorp Pharmaceuticals Private Limitedthis company | ₹1.69 Lakh (FY 2024) | -₹3.2 Lakh | -189.5% | -98.0% | Bhopal, Madhya Pradesh, India | |
| Lutika Pharmaceuticals Private Limited | ₹1.68 Lakh (FY 2025) | 9.0% | Bharuch, Gujarat, India | |||
| Vbsys Pharmaceuticals Private Limited | ₹1.68 Lakh (FY 2025) | -68.0% | Lucknow, Uttar Pradesh, India | |||
| Vigilant Pharmaceuticals Private Limited | ₹1.68 Lakh (FY 2024) | -61.0% | Mumbai, Maharashtra, India | |||
| Akshar Pharma Private Limited | ₹1.68 Lakh (FY 2016) | Mumbai, Maharashtra, India | ||||
| KD Emrold Pharmaceuticals Private Limited | ₹1.67 Lakh (FY 2025) | -48.0% | Delhi, India |
To see the full peer comparison of Arcorp Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Arcorp Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Arcorp Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Arcorp Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 23AATCA0145L1ZM | Madhya Pradesh | Active | 20 Dec 2019 |
To see the full GST registrations and return filing status of Arcorp Pharmaceuticals Private Limited, buy the company report.
Recent activity
Arcorp Pharmaceuticals Private Limited has 5 board changes on record since 2019: 2 appointments and 3 cessations. The latest: Shiksha Singh ceased to be Additional Director on 29 Sep 2024.
Frequently asked questions
Arcorp Pharmaceuticals is an active private limited company based in Bhopal, Madhya Pradesh, India. The company works in medical equipment retail and distribution, within the healthcare industry. It was incorporated on 05 December 2019 (7+ years old) and is registered under CIN U24239MP2019PTC050263.
Arcorp Pharmaceuticals has 2 current directors:
- Anjna Singh - Director
- Shiksha Singh - Director
The latest financial statements of Arcorp Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2020 are in the company report.
The GSTIN of Arcorp Pharmaceuticals is 23AATCA0145L1ZM, registered in Madhya Pradesh.
The CIN (Corporate Identification Number) of Arcorp Pharmaceuticals is U24239MP2019PTC050263. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Arcorp Pharmaceuticals was incorporated on 05 December 2019, making it 7+ years old. It is registered with the Registrar of Companies, Gwalior.
The peers of Arcorp Pharmaceuticals by revenue are Ecolab Scientific Private Limited, Rivoma Pharmaceuticals Private Limited, Doctor Choice Pharmaceuticals Private Limited, Raquel Pharmaceuticals Private Limited, Insta Medsystems Private Limited and 5 more, all in the Healthcare industry (Healthcare Equipment Retail and Distribution, Pharmaceuticals).
Shiksha Singh ceased to be Additional Director on 29 Sep 2024. Santosh Kumar Jaiswal ceased to be Director on 26 Feb 2024. Shiksha Singh was appointed as Director on 26 Feb 2024. Arcorp Pharmaceuticals has 5 board changes on record in total.
Yes, Arcorp Pharmaceuticals is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
The registered office of Arcorp Pharmaceuticals is at 91B See Brass Appartment Zone – II M.P Nagar, Bhopal, Madhya Pradesh, India – 462011.
Arcorp Pharmaceuticals operates in the healthcare industry, in the medical equipment retail and distribution segment.

